Finance Leadership Rotations Program — Emerging Leader Track

Legend Biotech; Bridgewater (MA); On-site; USD 84,000 - 135,000; Full time

Job summary

Legend Biotech in Bridgewater, NJ offers a Finance Management Leadership Development Program for recent MBA graduates. This full-time, in-person role accelerates your growth through 3-4 strategic rotations across Finance, Procurement, Corporate Finance and Internal Audit.

You will gain executive mentorship, build deep financial expertise, and influence enterprise finance decisions in a fast-growing biotech environment.

Qualifications

• Recent MBA graduate (Class of 2022–2026) aiming for Sr. Manager/Finance leadership.
• 3–5 years of professional finance or accounting experience with progressive responsibility.
• Strong ownership, analytical thinking, and clear communication.
• Preferred concentration in Finance/Accounting and experience with enterprise tech automation/visualization/analytics.

Responsibilities

• Oversee 3-4 strategic rotations across finance functions including Finance & Accounting, Procurement, Corporate Finance, Internal Audit.
• Develop deep technical expertise and enterprise perspective through high-impact assignments.
• Participate in Leadership Development Series with executive mentorship.
• Influence financial strategy and finance operations in a fast-growing biotech.
• Drive enterprise-wide outcomes through strategic financial impact.

Skills

Financial modeling

Problem solving

Attention to detail

Communication skills

Ownership

Collaboration

Enterprise tech automation

Education

MBA (Recent graduate 2022–2026)

Tools

ERP/Finance systems

Data visualization tools

Analytics platforms

Job description

Legend Biotech in Bridgewater, NJ offers a Finance Management Leadership Development Program for recent MBA graduates. This full-time, in-person role accelerates your growth through 3-4 strategic rotations across Finance, Procurement, Corporate Finance and Internal Audit.

You will gain executive mentorship, build deep financial expertise, and influence enterprise finance decisions in a fast-growing biotech environment.